Moreover, the activator of Wnt/β-catenin signal pathway can attenuate the inhibition on the malignancy of ccRCC cells caused by TLN2 overexpression (Cai et al., 2022). Here, TLN2 is linked to nonpapillary renal cell carcinoma.